期刊文献+

塞来昔布促进人急性单核细胞白血病THP-1细胞凋亡 被引量:1

Celecoxib promots the apoptosis of acute monocytic leukemia THP-1 cell line
原文传递
导出
摘要 目的 :探讨选择性环氧合酶2(cyclooxygenase-2,COX-2)抑制剂塞来昔布对人急性单核细胞白血病细胞增殖和凋亡的影响。方法 :不同浓度的塞来昔布处理THP-1细胞后,应用MTS法检测THP-1细胞的增殖情况,FCM法检测细胞凋亡和细胞周期,蛋白质印迹法检测caspase-3剪切片段(cleaved-caspase-3)、聚腺苷二磷酸核糖聚合酶1剪切片段(cleaved poly ADP-ribose polymerase-1,cleaved-PARP-1)、核因子κB抑制剂激酶(βinhibitor of nuclear factor kappa B kinaseβ,IKKβ)、磷酸化IKKβ(phospho-IKKβ,p-IKKβ)、丝氨酸-苏氨酸蛋白激酶(seride-threonine protein kinase,又称Akt)、磷酸化Akt(phospho-Akt,p-Akt)和survivin蛋白的表达。结果 :不同浓度的塞来昔布均可抑制THP-1细胞的增殖,诱导THP-1细胞的凋亡,并将细胞阻滞于G0/G1期(P值均<0.05)。不同浓度的塞来昔布处理后,THP-1细胞中p-Akt、p-IKKβ和survivin蛋白的表达水平均显著下调(P值均<0.05);当塞来昔布的浓度大于6μmol/L时,THP-1细胞中cleaved-caspase-3和cleaved-PARP蛋白的表达水平均显著上调(P值均<0.05)。结论 :塞来昔布能抑制THP-1细胞的增殖并诱导细胞凋亡,这一作用可能与Akt/核因子κB(nuclear factor kappa B,NF-κB)信号通路及抗凋亡蛋白survivin的表达有关。 Objective: To investigate the inhibitor celecoxib on the myeloid leukemia cells. effects of cyclooxygenase-2 (COX-2) proliferation and apoptosis of acute Methods: After acute monocytic leukemia cell line THP-1 treatment with different concentrations of celecoxib, the proliferation, apoptosis and cell cycle distribution of THP-1 cells were detected by MTS and FCM, respectively. The expressions of cleaved-caspase-3, cleaved poly ADP-ribose polymerase-1 (cleaved-PARP-1), inhibitor of nuclear factor kappa-B kinase 13 (IKK13), phospho- IKKI3 (p-IKKI3), seride-threonine protein kinase (Akt), phospho-Akt (p-Akt) and survivin proteins in THP-1 cells were detected after treatment with different concentrations of celecoxib. Results: Different concentrations of celecoxib inhibited the proliferation of THP-1 cells, induced the apoptosis of THP-1 cells, and arrested the cell cycles of THP-1 cells at G0/G1 phase (all P 〈 0.05). The expression levels of p-Akt, p-IKKI3 and survivin proteins in THP-1 cells after treatment with different concentrations of celecoxib were significantly down- regulated (all P 〈 0.05), while the expression levels of cleaved-caspase-3 and cleaved- PARP-1 in THP-1 cells after treatment with celecoxib (〉 6 μmol/L) were significantly upregulated (all P 〈 0.05). Conclusion: Celecoxib can inhibit the proliferation and induce the apoptosis of THP-1.This effect may be related to Akt/nuclear factor kappa B (NF-KB) signaling pathway and the expression of anti-apoptotic protein survivin.
出处 《肿瘤》 CAS CSCD 北大核心 2016年第8期874-881,共8页 Tumor
关键词 白血病 单核细胞 急性 环氧合酶2抑制剂 细胞增殖 细胞凋亡 Leukemia, monocytic, acute Cyclooxygenase 2 inhibitor Cell proliferationApoptosis
  • 相关文献

参考文献2

二级参考文献24

  • 1Kopp KL,Dabelsteen S,Krejsgaard T,et al.COX-2 is a novel target in therapy of mycosis fungoides.Leukemia,2010;24(12):2127-2129.3.
  • 2Subhashini J,Mahipal SV,Reddanna P.Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro.Cancer Lett,2005 ;224(1):31-43.
  • 3Quentmeier H,Reinhardt J,Zaborski M,et al.FLT3 mutations in acute myeloid leukemia cell lines.Leukemia,2003 ; 17 (1):120-124.
  • 4Grimwade D,Mrózek K.Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia.Hematol Oncol Clin North Am,2011;25(6):1135-1161.
  • 5Ravandi F,Burnett AK,Agura ED,et al.Progress in the treatment of acute myeloid leukemia.Cancer,2007 ; 110:1900-1910.
  • 6Zhong L,Jia YQ,Meng WT,et al.FMS-like tyrosine kinase 3 internal tandem duplication and the patterns of its gene sequence in 207 Chinese patients with de novo acute myeloid leukemia.Arch Pathol Lab Med,2012;136(1):84-89.
  • 7Leung AY,Man CH,Kwong YL.FLT3 inhibition:a moving and evolving target in acute myeloid leukemia.Leukemia,2013 ; 27 (2):260-268.
  • 8Lin PH,Lin CC,Yang HI,et al.Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3.Leuk Res,2013;37(3):287-292.
  • 9Pratz KW,Sato T,Murphy KM,et al.FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.Blood,2010;115(7):1425-1432.
  • 10Schittenhelm MM,Kampa KM,Yee KW,Heinrich MC.The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin.Cell Cycle,2009;8(16):2621-2630.

共引文献16

同被引文献16

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部